EXECUTIVE SUMMARY
Overview
Trends and Opportunities
Market Leaders
SECTION 1:
ENERGY-BASED THERAPIES BY DISEASE STATE AND TECHNOLOGY
1.1
Cancer
1.1.1
Cryogenic therapy
1.1.2
Microwave therapy
1.1.3
Radiation therapy
1.1.4
Radiofrequency ablation
1.1.5
Stereotactic surgery
1.1.6
Thermal ablation
1.1.7
Laser ablation
1.1.8
Photodynamic therapy
1.1.9
Ultrasonic ablation
1.2 Cardiovascular disease
1.2.1
Angina pectoris
1.2.2
Atrial arrhythmias
1.2.2.1 Laser ablation
1.2.2.2 Cryoablation
1.2.2.3 Electrical
cardioversion
1.2.2.4 Microwave
ablation
1.2.2.5 RF ablation
1.2.3
Bradycardia
1.2.4
Critical ischaemia
1.2.5
Vascular occlusive disease
1.2.6
Ventricular arrhythmias
1.2.7
Wolf-Parkinson-White Disease
1.3
Elective surgery
1.3.1
Cosmetic surgery
1.3.1.1 Laser hair
removal
1.3.1.2 Port wine
stains
1.3.1.3 Psoriasis
1.3.1.4 Varicose veins
1.3.2
Ophthalmic surgery
1.3.2.1 Capsulotomy
surgery
1.3.2.2 Laser in-situ
keratomileusis (LASIK)
1.3.2.2.1
Wave-front guided laser in-situ keratomileusis
1.3.2.3 Laser
epithelial keratomileusis (LASEK)
1.4
General surgery
1.4.1 Fecal incontinence
1.4.2 GERD
1.5
Gynecological applications
1.5.1 Hysterectomy
1.5.2 Menorrhagia
1.5.3 Bladder neck
suspension
1.5.4 Fibroids
1.6
Urological applications
1.6.1
Urinary tract stones
1.6.2
Benign prostatic hypertrophy
1.6.2.1 TUMT
1.6.2.2 TUNA
1.6.2.3 Vaporization of
the prostate (PVP)
1.6.2.4 Water-induced
thermotherapy
1.7
Orthopedic applications
1.7.1
Capsular shrinkage
1.7.2 Carpal tunnel
syndrome
1.7.3 Chondroplasty
1.7.4 Debridement
1.7.5 Epicondylitis and
tendinitis
1.7.6 Inflammatory
conditions
1.7.7 Nucleoplasty
Section 2: PRODUCTS AND TECHNOLOGIES
2.1
Cryogenic energy
2.2
Electrical energy
2.2.1
Implantable cardioverter
defbibrillators
2.2.2
Resynchronisation systems
2.2.3
Pacing systems
2.2.4
Pain management
2.3
Hydromechanical energy
2.4
Light energy
2.4.1
Cold lasers
2.4.2
Excimer lasers
2.4.3
Photonic ablation
2.4.4
Ultraviolet B lasers
2.5
Microwave energy
2.6
Radiation energy
2.6.1
Brachytherapy
2.6.2
Radiosurgery
2.6.2.1 Cyberknife
2.6.2.2 Gamma knife
2.7
Radiofrequency energy
2.8
Thermal energy
2.9
Ultrasonic energy
2.6.2.1 Shock wave therapy
2.6.2.2 Ultrasonic surgical
systems
Section
3: ABLATION TECHNOLOGIES MARKET
3.1
World market overview
3.2
Market segmentation by product type
3.3
Leading companies in global market
3.4
Major national markets
3.4.1
Americas
3.4.1.1
USA
3.4.1.2
Canada
3.4.1.3
Mexico
3.4.1.4
Brazil
3.4.2
Europe
3.4.2.1
Germany
3.4.2.2
United Kingdom
3.4.2.3
France
3.4.2.4
Italy
3.4.2.5
Spain
3.4.2.6
Benelux countries
3.4.3
Asia/Pacific
3.4.3.1
Japan
3.4.3.2
China
3.4.3.3
Australia
3.4.3.4
South Korea
3.4.3.5
India
3.4.4
Rest of world
Section
4:
COMPANY PROFILES
4.1 The Industry
4.1.1 Abla-TX
4.1.1.1 Role in Cancer Treatment
4.1.2 Acoustic MedSystems
4.1.3 Accuray
4.1.4 ACMI/Gyrus/Olympus
4.1.5 AFx (Guidant)
4.1.6 Alcon
4.1.7 American Medical Systems
4.1.8 Angiodynamics
4.1.8.1 Financials
4.1.9 ArthroCare Corporation
4.1.10 AtriCure, Inc.
4.1.11 ATS Medical
4.1.11.1 Financial results
4.1.12 Bard EP
4.1.13 Bausch & Lomb (Warburg Pincus)
4.1.14 Baylis Medical Company
4.1.15 Biosense Webster
4.1.16 Biotronik Inc.
4.1.17 Biowave Corp
4.1.18 Boston Scientific Corp
4.1.18.1 Blazer Cardiac Ablation
Catheters
4.1.18.2 Chilli Cooled Ablation
Catheters
4.1.18.3 Steerocath-T Cardiac Ablation
Catheter
4.1.18.4 Maestro
4.1.18.5 RF 3000® Radiofrequency
Ablation System
4.1.18.6 Confient Implantable
Cardioverter Defibrillator (ICD)
4.1.18.7 Financials
4.1.19 BSD Medical Corp.
4.1.19.1 MicroThermX-100 Microwave
Ablation Systems
4.1.19.2 BSD500 Hyperthermia Systems
4.1.19.3 BSD2000 Hyperthermia Systems
4.1.20 Candela Corp.
4.1.21 Cardima Inc
4.1.22 CardioGenesis Corp
4.1.23 Celon AG
4.1.23.1 Surgery/Radiology
4.1.23.2 Phlebology
4.1.24 Celsion Corp.
4.1.25 ConMed Corp.
4.1.26 Covidien Ltd.
4.1.26.1 Vessel Sealing
4.1.26.2 Electrosurgery
4.1.26.3 Financial Results for fiscal
2007 and 2006
4.1.27 CryoCath
4.1.28 CryoCor, Inc.
4.1.29 CSA Medical Inc.
4.1.30 Cytyc Corp.
4.1.31 Dornier MedTech
4.1.31.1 Compact Delta II
4.1.31.2 Compact Delta II UIMS
4.1.31.3 Compact Sigma
4.1.31.4 Lithotripter S II
4.1.31.5 Medilas D MultiBeam
4.1.31.6 Medilas D FlexiPulse
4.1.31.7 Medilas H 20
4.1.32 EDAP TMS S.A.
4.1.32.1 Financial Update
4.1.33 Elekta
4.1.33.1 Leksell Gamma Knife 4
4.1.33.2 Leksell Gamma Knife 4C
4.1.33.3 Leksell Gamma Knife Perfexion
4.1.34 Endocare
4.1.35 Erbe
4.1.35.1 Electrosurgery
4.1.35.2 Water Jet Surgery
4.1.35.3 Cryosurgery
4.1.36 Ethicon Endo-Surgery Inc.
4.1.37 Galil Medical
4.1.38 Getinge Group
4.1.38.1 Cardiac Surgery
4.1.38.2 Vascular Surgery
4.1.39 HealthTronics Surgical Services
4.1.39.1 Medical Products
4.1.39.2 Urology Services
4.1.40 Medtronic
4.1.40.1 Cardiac Rhythm Disease
Management (CRDM)
4.1.40.2 Bradycardia
4.1.40.3 Tachyarrhythmia
4.1.40.4 Ablation Catheters
4.1.41 MedWaves Inc.
4.1.42 Mirabilis Medica
4.1.43 Misonix Inc.
4.1.43.1 Sonablate
4.1.44 NeuWave Medical Inc.
4.1.45 Olympus Medical
4.1.46 OmniSonics Medical Technologies Inc.
4.1.47 PhotoMedex Inc.
4.1.48 PhotoTherapeutics Inc.
4.1.49 PhotoThera Inc.
4.1.50 RFA Medical Inc.
4.1.51 Smith & Nephew
4.1.51.1 Financial Results
4.1.52 Spectranetics
4.1.53 St Jude Medical Inc.
4.1.53.1 Products for Cardiac Rhythm
Management
4.1.53.2 Atrial Fibrillation
4.1.53.3 Advanced Neuromodulation
Systems
4.1.54 Starion Instruments
4.1.55 Stereotaxis Inc.
4.1.55.1 Stereotaxis Magnetic
Navigation System
4.1.56 Theragenics Corporation
4.1.57 Urologix Inc
4.1.57.1 Targis System
4.1.58 USHIFU
4.1.59 Varian Medical Systems Inc.
4.1.59.1 RapidArc
4.1.59.2 Dynamic Targeting Image-Guided
Radiation Therapy (IGRT)
4.1.59.3 SmartBeam IMRT
4.1.59.4 Dynamic Adaptive Radiotherapy
(DART)
4.1.59.5 IGBT - Image-Guided
Brachytherapy
4.1.59.6 Varian Proton Therapy System
4.1.60 VNUS Medical Technologies, Inc.
4.1.60.1 ClosureFAST System
4.1.60.2 Model RFG2 Advanced
Radiofrequency Generator
4.1.60.3 Quarterly Financials
APPENDIX:
COMPANY DETAILS
List of Exhibits
Exhibit ES-1: Overview of the Global Ablation and
Other Energy-Based Therapies Market by Modality
Exhibit ES-2: Growth of the Worldwide Ablation and Other
Energy-Based Therapies Market by Modality
Exhibit ES-3: Worldwide Ablation and Other Energy-Based Therapies
Market by Clinical Applicatio
Exhibit ES-4: Market Leaders in Energy-Based Therapies
Exhibit 1-1: Energy-Based Treatment Options for
Prostate Cancer
Exhibit 1-2: Energy-Based Therapies for
Cardiovascular Diseases
Exhibit 1-3: Energy-based Therapies for Atrial
Arrhythmias
Exhibit 1-4: Ventricular Arrhythmia Therapies
Exhibit 1-5: Energy-based Implants for Ventricular
Arrhythmias
Exhibit 1-6: Cosmetic Lasers
Exhibit 1-7: Traditional LAVH vs PK LVAH
Exhibit 1-8: Orthopedic Application of
Electrosurgical Devices
Exhibit 1-9: Collagen Types
Exhibit 1-10: Chondroplasty Systems’ Zone of Thermal
Damage
Exhibit 2-1: Energy-Based Technologies
Exhibit 2-2: Cryogenic-Energy Ablation Products
Exhibit 2-3: Electrical-Energy Ablation Products
Exhibit 2-4: Hydromechanical Ablation Products
Exhibit 2-5: Light-Energy Ablation Products
Exhibit 2-6: Microwave Ablation Products
Exhibit 2-7: Radiation-Energy Ablation Products
Exhibit 2-8: Radioactive Seed Products for
Brachytherapy
Exhibit 2-9: Radiofrequency (RF) Ablation Products
Exhibit 2-10: Thermal-Energy Ablation Products
Exhibit 2-11: Ultrasound Ablation Products
Exhibit 2-12: High Growth Applications of Ultrasonic
Surgical Systems
Exhibit 3-1: World Medical Device Market, by Region,
2008
Exhibit 3-2: World Energy-based Device Market by
Product Category, 2007
Exhibit 3-3: Overview of the Energy-Based Therapies
Market by Clinical Application
Exhibit 3-4: Arrhythmias Treated with Ablation
Therapy
Exhibit 3-5: 25-Year Changes in National Mortality
Rates Due to Ischaemic Heart Disease
Exhibit 3-6: Cardiac Angioplasty Procedures Per
100,000 Population, By Country in 2000
Exhibit 3-7: Cardiac Dysrhythmias and Related
Conditions
Exhibit 3-8: Solid cancers: Ablation Market
Potential
Exhibit 3-9: World Age-Standardize Cancer Incidence
per 100, 000 Population (All Ages), by Cancer Type
Exhibit 3-10: Global Energy-based Therapies Market,
by Product Category
Exhibit 3-11: World Energy-based Device Market by
Product Category, 2007 and 2017
Exhibit 3-12: Ablation and Energy-based Therapeutic
Companies by Product Area, Indication and Market Shares, Worldwide,
2008
Exhibit 3-13: Ablation Market Revenues ($millions),
Americas, by Country, 2007-2017
Exhibit 3-14: Ablation Market Revenues ($000s) US,
by Product Segment, 2007-2017
Exhibit 3-15: Ablation Market Revenues ($000s),
Canada, by Product Segment, 2007-2017
Exhibit 3-16: Ablation Market Revenues ($000s),
Brazil, by Product Segment, 2007-2017
Exhibit 3-17: Ablation Market Revenues ($000s),
Mexico, by Product Segment, 2007-2017
Exhibit 3-18: Ablation Market Revenues ($millions),
Europe, by Country, 2007-2017
Exhibit 3-19: Ablation Market Revenues ($000s),
Germany, by Product Segment, 2007-2017
Exhibit 3-20: Ablation Market Revenues ($000s),
United Kingdom, by Product Segment, 2007-2017
Exhibit 3-21: Ablation Market Revenues ($000s),
France, by Product Segment, 2007-2017
Exhibit 3-22: Ablation Market Revenues ($000s),
Italy, by Product Segment, 2007-2017
Exhibit 3-23: Ablation Market Revenues ($000s),
Spain, by Product Segment, 2007-2017
Exhibit 3-24: Ablation Market Revenues ($000s),
BeNeLux, by Product Segment, 2007-2017
Exhibit 3-25: Ablation Market Revenues ($millions),
Asia/Pacific, by Country, 2007-2017
Exhibit 3-26: Ablation Market Revenues ($000s),
Japan, by Product Segment, 2007-2017
Exhibit 3-27: Ablation Market Revenues ($000s),
China, by Product Segment, 2007-2017
Exhibit 3-28: Ablation Market Revenues ($000s),
India, by Product Segment, 2007-2017
Exhibit 3-29: Ablation Market Revenues ($000s),
Australia, by Product Segment, 2007-2017
Exhibit 3-30: Ablation Market Revenues ($millions),
Rest of World, 2007-2017
Exhibit 3-31: Ablation Market Revenues ($000s), Rest
of World, by Product Segment, 2007-2017
Exhibit 4-1: M&A Activity Among Energy-based
Companies
Exhibit 4-2: AngioDynamics Financial Figures for
Fiscal 2007 and 2006
Exhibit 4-3: ATS Financial Results for Q2 2008 and
2007
Exhibit 4-4: Boston Scientific Financials, Three
Months Ended June 30, 2007 & 2008
Exhibit 4-5: CardioGenesis Financial Data, 2006
&2007
Exhibit 4-6: Covidien Ltd Financial Results, 2006 &
2007
Exhibit 4-7: Covidien Medical Device sales by Product
Group
Exhibit 4-8: EDAP TMS Financial Results, 1st Quarter
2008 (to March 31st)
Exhibit 4-9: Endocare Quarterly Results, 2007 & 2008
Exhibit 4-10: Medtronic Revenues, 2007
Exhibit 4-11: Six-month Financial Data for Smith &
Nephew, 2007 & 2008
Exhibit 4-12: TheraGenics Financial Results, Fourth
Quarter 2007 and Full Year
Exhibit 4-13: Varian Medical Systems, Financial
Summary, 2005-2007
Contact: Patrick Driscoll, (949) 859-3401.
Copyright © 2008 MedMarket Diligence, LLC. All rights
reserved.
Revised: 10/06/08
